EUVIMEDEUVIMED entdecken
Crossref

Molecular and Phenotypic Characterization of Gentamicin Resistance in Clinical Acinetobacter Isolate

Masoumeh Ravand, Shafighi, Seyede Tooba

Biotechnological Journal of Environmental Microorganisms (Bioem) · 03.08.2024

DOI: 10.71886/bioem.2024.1217872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnological Journal of Environmental Microorganisms (Bioem), erschienen am 03.08.2024. Verfasst von Masoumeh Ravand und 2 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acinetobacter spp. are opportunistic nosocomial pathogens notorious for their multidrug resistance, complicating the treatment of infections such as bacteremia and pneumonia. The dissemination of aminoglycoside resistance genes, particularly via integrons, is a major therapeutic concern. This study aimed to characterize gentamicin resistance in clinical Acinetobacter isolates using phenotypic and molecular methods. Thirty Acinetobacter isolates were collected from medical centers in Lahijan and Amlash, Iran. Gentamicin resistance was phenotypically assessed by disk diffusion and macrodilution MIC methods per CLSI guidelines. Genotypically, the presence of the *aac(3)-IV* aminoglycoside resistance gene was detected by PCR following DNA extraction. Disk diffusion identified 40% of isolates as gentamicin-resistant. The macrodilution method confirmed resistance in 33.33% of isolates, with MIC values ranging from 7.81 μg/mL to 125 μg/mL. The *aac(3)-IV* gene was detected in 30% of all isolates. The high prevalence of the *aac(3)-IV* gene underscores its significant contribution to gentamicin resistance in these clinical isolates. Integrating molecular detection with phenotypic screening is crucial for surveillance and informs effective empirical therapy to combat multidrug-resistant Acinetobacter infections in the Guilan region.

Schlagwörter

Acinetobactergentamicin resistanceaminoglycoside resistanceintegronsmultidrug resistancenosocomial pathogensminimum inhibitory concentrationantimicrobial susceptibility

Zitieren

APA

Ravand, M., Shafighi, & Tooba, S. (2024). Molecular and Phenotypic Characterization of Gentamicin Resistance in Clinical Acinetobacter Isolate. Biotechnological Journal of Environmental Microorganisms (Bioem). https://doi.org/10.71886/bioem.2024.1217872

Vancouver

Ravand M, Shafighi, Tooba S. Molecular and Phenotypic Characterization of Gentamicin Resistance in Clinical Acinetobacter Isolate. Biotechnological Journal of Environmental Microorganisms (Bioem). 2024. doi:10.71886/bioem.2024.1217872

BibTeX
@article{Ravand2024,
  author = {Ravand, Masoumeh and Shafighi and Tooba, Seyede},
  title = {Molecular and Phenotypic Characterization of Gentamicin Resistance in Clinical Acinetobacter Isolate},
  journal = {Biotechnological Journal of Environmental Microorganisms (Bioem)},
  year = {2024},
  doi = {10.71886/bioem.2024.1217872}
}
Kostenlos starten →